Back to Journals » The Application of Clinical Genetics » Volume 6
Clinical impact of recent genetic discoveries in osteoporosis
Authors Mitchell BD, Streeten EA
Received 25 July 2013
Accepted for publication 3 September 2013
Published 4 October 2013 Volume 2013:6 Pages 75—85
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Braxton D Mitchell, Elizabeth A Streeten
Department of Medicine and Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, and Geriatric Research and Education Clinical Center, Veterans Administration Medical Center, Baltimore, MD, USA
Abstract: Osteoporotic fracture carries an enormous public health burden in terms of mortality and morbidity. Current approaches to identify individuals at high risk for fracture are based on assessment of bone mineral density and presence of other osteoporosis risk factors. Bone mineral density and susceptibility to osteoporotic fractures are highly heritable, and over 60 loci have been robustly associated with one or both traits through genome-wide association studies carried out over the past 7 years. In this review, we discuss opportunities and challenges for incorporating these genetic discoveries into strategies to prevent osteoporotic fracture and translating new insights obtained from these discoveries into development of new therapeutic targets.
Keywords: bone mineral density, genome-wide association studies, osteoporosis, prediction, fracture, genetics
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.